X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/latest-updates-of-viva-biotechs-portfolio-companies-302081340.html
https://www.prnewswire.com/news-releases/viva-biotechs-portfolio-company-riparian-pharmaceuticals-announces-exclusive-license-agreement-and-research-agreement-with-pfizer-for-novel-cardiovascular-programs-301882021.html
https://www.prnewswire.com/news-releases/viva-biotech-announced-strategic-investors-with-an-investment-of-approximately-us-210-million-301852825.html
https://www.prnewswire.com/news-releases/viva-biotech-attended-sapa-china-301796354.html
https://www.fiercebiotech.com/biotech/eli-lilly-backed-ipinovyx-bio-emerges-10m-for-2023-clinical-entry
https://www.prnewswire.com/news-releases/viva-biotech-and-biomap-reached-a-strategic-collaboration-agreement-to-jointly-accelerate-the-early-drug-discovery-through-ai-technology-301287379.html
https://www.asiaone.com/business/viva-biotech-and-synthesis-enters-strategic-acquisition-agreement-accelerating-development
https://www.prnewswire.com/news-releases/viva-biotechs-portfolio-company-dogma-therapeutics-reached-the-acquisition-agreement-with-astrazeneca-on-dogmas-oral-pcsk9-inhibitor-program-301133208.html
https://www.biospectrumasia.com/news/40/16515/viva-biotech-acquires-major-stake-in-chinese-cdmo.html
Market Place
Share 
